Hassan Zair, Ali Iftikhar, Ullah Arslan R, Ahmed Raheel, Zar Adnan, Ullah Irfan, Rehman Shakeel, Khan Aziz Ullah, Ullah Rizwan, Hanif Muhammad
Cardiology, Lady Reading Hospital, Peshawar, PAK.
Pharmacy, Paraplegic Center, Peshawar, PAK.
Cureus. 2021 Feb 20;13(2):e13449. doi: 10.7759/cureus.13449.
Background Inappropriate medication dosing can cause adverse drug reactions or ineffective therapy due to declined renal function in patients with renal insufficiency. This necessitates proper renal dose adjustment. This study was proposed to evaluate medication dosage adjustment in hospitalized chronic kidney disease (CKD) patients. Methods This study included all CKD patients hospitalized between May 1, 2019, and April 25, 2020, at the Institute of Kidney Disease, Peshawar, Pakistan. The estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease formula, and dose appropriateness was established by evaluating practice with relevant reference books. Results Of the total 1,537 CKD patients, 231 (15.03%) had evidence of dosing error, which was considered for final analysis. Overall, 1,549 drugs were prescribed; 480 (30.99%) drugs required dose adjustment, of which 196 (40.42%) were adjusted properly and the remaining 286 (59.58%) were unadjusted. The most common unadjusted drugs were meropenem, cefepime, ciprofloxacin, and rosuvastatin, whereas captopril, aspirin, bisoprolol, pregabalin, and levofloxacin had the highest percentage of adjusted drugs. On multivariate logistic regression, the number of drugs requiring dosing adjustments and obstructive nephropathy were found to be statistically significant factors that increased the likelihood of the medication dosing errors: a unit increase in the number of drugs requiring dose adjustment increases 5.241 times the likelihood of dosing error. Similarly, the presence of obstructive nephropathy (OR: 0.383; 95% Cl: 0.153-0.960; p = 0.041) was found to be significantly associated with dosing error after adjustment for potential confounding factors. Conclusion The dosing of more than half of the prescribed drugs that required adjustment in CKD patients was not adjusted, which showed that medication dosing errors were high. This highlights the importance of medication prescription according to guidelines in these patients to improve the outcomes of pharmacotherapy.
在肾功能不全患者中,由于肾功能下降,不适当的药物剂量可能会导致药物不良反应或治疗无效。因此需要进行适当的肾脏剂量调整。本研究旨在评估住院慢性肾脏病(CKD)患者的药物剂量调整情况。
本研究纳入了2019年5月1日至2020年4月25日期间在巴基斯坦白沙瓦肾病研究所住院的所有CKD患者。使用肾脏病饮食改良公式计算估算肾小球滤过率,并通过参考相关书籍评估实践来确定剂量是否合适。
在总共1537例CKD患者中,231例(15.03%)有用药错误的证据,这些患者被纳入最终分析。总体而言,共开具了1549种药物;480种(30.99%)药物需要调整剂量,其中196种(40.42%)调整得当,其余286种(59.58%)未调整。最常见的未调整药物是美罗培南、头孢吡肟、环丙沙星和瑞舒伐他汀,而卡托普利、阿司匹林、比索洛尔、普瑞巴林和左氧氟沙星的调整药物比例最高。多因素逻辑回归分析发现,需要调整剂量的药物数量和梗阻性肾病是增加用药错误可能性的统计学显著因素:需要调整剂量的药物数量每增加一个单位,用药错误的可能性增加5.241倍。同样,在调整潜在混杂因素后,发现梗阻性肾病的存在(OR:0.383;95%CI:0.153 - 0.960;p = 0.041)与用药错误显著相关。
CKD患者中超过一半需要调整剂量的处方药未进行调整,这表明用药错误率很高。这凸显了根据指南为这些患者开具药物处方以改善药物治疗效果的重要性。